J.P. Morgan 37th Annual Healthcare Conference

Publié le 12/12/2018

7 – 10 January, 2019

San Francisco, USA

“ENYO Pharma team will be at San Francisco during the J.P. Morgan conference, which is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.” (jpmorgan.com)

À lire dans 'Événements'

• ASN 2025 - American Society of Nephrology
• The 2025 International Workshop on Alport Syndrome
• ENYO Pharma annonce la finalisation de son financement de série C avec Vesalius Biocapital et la poursuite de son étude clinique de phase 2 ALPESTRIA-1
• BIO International Convention
• Alport Connect 2025, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport